» Articles » PMID: 36970142

The Mycothiol -transferase is Divalent Metal-dependent for Mycothiol Binding and Transfer

Overview
Journal RSC Med Chem
Specialty Chemistry
Date 2023 Mar 27
PMID 36970142
Authors
Affiliations
Soon will be listed here.
Abstract

Mycothiol -transferase (MST) (encoded by the gene) was previously identified as the enzyme responsible for the transfer of Mycothiol (MSH) to xenobiotic acceptors in () during xenobiotic stress. To further characterize the functionality of MST and the possible roles , X-ray crystallographic, metal-dependent enzyme kinetics, thermal denaturation studies, and antibiotic MIC determination in knockout strain were performed. The binding of MSH and Zn increases the melting temperature by 12.9 °C as a consequence of the cooperative stabilization of MST by both MSH and metal. The co-crystal structure of MST in complex with MSH and Zn to 1.45 Å resolution supports the specific utilization of MSH as a substrate as well as affording insights into the structural requirements of MSH binding and the metal-assisted catalytic mechanism of MST. Contrary to the well-defined role of MSH in mycobacterial xenobiotic responses and the ability of MST to bind MSH, cell-based studies with an knockout strain failed to provide evidence for a role of MST in processing of rifampicin or isoniazid. These studies suggest the necessity of a new direction to identify acceptors of the enzyme and better define the biological role of MST in mycobacteria.

Citing Articles

The crystal structure of mycothiol disulfide reductase (Mtr) provides mechanistic insight into the specific low-molecular-weight thiol reductase activity of Actinobacteria.

Gutierrez-Fernandez J, Hersleth H, Hammerstad M Acta Crystallogr D Struct Biol. 2024; 80(Pt 3):181-193.

PMID: 38372589 PMC: 10910545. DOI: 10.1107/S205979832400113X.

References
1.
Hernick M . Mycothiol: a target for potentiation of rifampin and other antibiotics against Mycobacterium tuberculosis. Expert Rev Anti Infect Ther. 2013; 11(1):49-67. DOI: 10.1586/eri.12.152. View

2.
Winn M, Ballard C, Cowtan K, Dodson E, Emsley P, Evans P . Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 4):235-42. PMC: 3069738. DOI: 10.1107/S0907444910045749. View

3.
Evans P . Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr. 2005; 62(Pt 1):72-82. DOI: 10.1107/S0907444905036693. View

4.
Newton G, Unson M, Anderberg S, Aguilera J, Oh N, delCardayre S . Characterization of Mycobacterium smegmatis mutants defective in 1-d-myo-inosityl-2-amino-2-deoxy-alpha-d-glucopyranoside and mycothiol biosynthesis. Biochem Biophys Res Commun. 1999; 255(2):239-44. DOI: 10.1006/bbrc.1999.0156. View

5.
Rawat M, Newton G, Ko M, Martinez G, Fahey R, Av-Gay Y . Mycothiol-deficient Mycobacterium smegmatis mutants are hypersensitive to alkylating agents, free radicals, and antibiotics. Antimicrob Agents Chemother. 2002; 46(11):3348-55. PMC: 128700. DOI: 10.1128/AAC.46.11.3348-3355.2002. View